Literature DB >> 10623428

Identification of bone morphogenetic proteins and their receptors in human breast cancer cell lines: importance of BMP2.

S F Arnold1, E Tims, B E Mcgrath.   

Abstract

The most frequent site of breast cancer metastasis is bone suggesting that some breast cancers express proteins that facilitate this process. We evaluated whether a highly metastatic breast cancer cell line, MDA-MB-231, and a less metastatic breast cancer cell line, MCF-7, contain bone morphogenetic proteins (BMP). Semiquantitative reverse transcriptase-polymerase chain reaction (RT-PCR) demonstrated that MDA and MCF-7 cells contain mRNAs for BMP receptors IA, IB and II. RT-PCR indicated the presence of mRNAs for BMPs 2 and 3 but not 4 and 7 in breast cells. Using a RT-PCR strategy with molecular beacons, we found that the mRNA for BMP2 in MDA cells was decreased by 75% after a sublethal dose of radiation. An ELISA using an antibody specific for BMP2 demonstrated that BMP2 protein was reduced after radiation of MDA cells. The mRNA for BMP2 was expressed to a lesser extent in MCF-7 cells than MDA cells and was not altered after radiation treatment of MCF-7 cells as demonstrated by molecular beacon RT-PCR. Recombinant human BMP2 decreased the proliferation of MDA cells to a greater extent than MCF-7 cells. These results expand the number of tissues that contain BMPs and demonstrate the effect of this signalling pathway of the growth state of these tissues. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10623428     DOI: 10.1006/cyto.1999.0508

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  18 in total

1.  Construction of a eukaryotic expression vector pEGFP-C1-BMP-2 and its effect on cell migration.

Authors:  Xiao-ying Wang; Zhong-hua Chen; Ru-yi Zhang; Sen-quan Liu; Zhu Mei; Ying-ying Yu; Xiong Zhang; Qiang Xia; Yue-min Ding
Journal:  J Zhejiang Univ Sci B       Date:  2012-05       Impact factor: 3.066

Review 2.  The Yin and Yang of bone morphogenetic proteins in cancer.

Authors:  Ashok Singh; Rebecca J Morris
Journal:  Cytokine Growth Factor Rev       Date:  2010-08-04       Impact factor: 7.638

3.  Bone morphogenetic protein 2 (BMP-2) and induction of tumor angiogenesis.

Authors:  Martin Raida; Joachim H Clement; Russell D Leek; Kurosh Ameri; Roy Bicknell; Dietger Niederwieser; Adrian L Harris
Journal:  J Cancer Res Clin Oncol       Date:  2005-11-01       Impact factor: 4.553

4.  SOSTDC1 differentially modulates Smad and beta-catenin activation and is down-regulated in breast cancer.

Authors:  Kathryn A Clausen; Kimberly R Blish; Charles E Birse; Matthew A Triplette; Timothy E Kute; Gregory B Russell; Ralph B D'Agostino; Lance D Miller; Frank M Torti; Suzy V Torti
Journal:  Breast Cancer Res Treat       Date:  2010-11-27       Impact factor: 4.872

5.  Bone morphogenetic protein signaling and growth suppression in colon cancer.

Authors:  Stayce E Beck; Barbara H Jung; Antonio Fiorino; Jessica Gomez; Eunice Del Rosario; Betty L Cabrera; Sherry C Huang; Jimmy Y C Chow; John M Carethers
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-07       Impact factor: 4.052

6.  MicroRNA-129-5p promotes proliferation and metastasis of hepatocellular carcinoma by regulating the BMP2 gene.

Authors:  Zengyao Liu; Jiefei Sun; Xiaochun Wang; Zhenyuan Cao
Journal:  Exp Ther Med       Date:  2021-01-25       Impact factor: 2.447

7.  The correlation of bone morphogenetic protein 2 with poor prognosis in glioma patients.

Authors:  Xiangshan Yang; Daotang Li; Shaomei Cheng; Kaixi Fan; Lijun Sheng; Jing Zhang; Bin Feng; Zhongfa Xu
Journal:  Tumour Biol       Date:  2014-08-07

8.  Bone morphogenetic protein-2 levels are elevated in the patients with gastric cancer and correlate with disease progression.

Authors:  Yong Park; Myoung Hee Kang; Hee Yeon Seo; Joong Min Park; Chul Won Choi; Yeul Hong Kim; In Sun Kim; Jun Suk Kim; Sang Cheul Oh
Journal:  Med Oncol       Date:  2009-11-19       Impact factor: 3.064

9.  Humoral bone morphogenetic protein 2 is sufficient for inducing breast cancer microcalcification.

Authors:  Fangbing Liu; Nathalie Bloch; Kumar R Bhushan; Alec M De Grand; Eiichi Tanaka; Stephanie Solazzo; Pawel M Mertyna; Nahum Goldberg; John V Frangioni; Robert E Lenkinski
Journal:  Mol Imaging       Date:  2008 Jul-Aug       Impact factor: 4.488

10.  The Bone Morphogenesis Protein-2 (BMP-2) is associated with progression to metastatic disease in gastric cancer.

Authors:  Yong Park; Jee Won Kim; Dae Sik Kim; Eui Bae Kim; Se Jong Park; Jin Yong Park; Woo Suk Choi; Jong Gyu Song; Hee Yun Seo; Sang Cheul Oh; Byung Soo Kim; Jong Jae Park; Yeul Hong Kim; Jun Suk Kim
Journal:  Cancer Res Treat       Date:  2008-09-30       Impact factor: 4.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.